Circadian rhythm-modulated chemotherapy with high-dose 5-fluorouracil: a pilot study in patients with pancreatic adenocarcinoma
- 31 December 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (13), 1851-1854
- https://doi.org/10.1016/0959-8049(93)90536-o
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Colony-forming unit-granulocyte-macrophage and DNA synthesis of human bone marrow are circadian stage-dependent and show covariationBlood, 1992
- A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancerCancer, 1992
- Pancreatic CarcinomaNew England Journal of Medicine, 1992
- Circadian changes in estimated hepatic blood flow in healthy subjects.British Journal of Clinical Pharmacology, 1991
- DNA synthesis in human bone marrow is circadian stage dependentBlood, 1991
- A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatinCancer, 1990
- Dihydropyrimidine Dehydrogenase Activity in Human Blood Mononuclear CellsEnzyme, 1989
- Circadian rhythm of rat liver dihydropyrimidine dehydrogenaseBiochemical Pharmacology, 1988
- Effect of Biological Time on the Determination of the LD50 of 5-Fluorouracil in MicePharmacology, 1984
- Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial.BMJ, 1980